Literature DB >> 4625395

Complement studies in membrano-proliferative glomerulonephritis.

D K Peters, A Martin, A Weinstein, J S Cameron, T M Barratt, C S Ogg, P J Lachmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4625395      PMCID： PMC1553661     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  21 in total

Review 1.  Chemistry and reaction mechanisms of complement.

Authors:  H J Müller-Eberhard
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

2.  The biologic activities of guinea pig antibodies. II. Modes of complement interaction with gamma 1 and gamma 2-immunoglobulins.

Authors:  A L Sandberg; A G Osler; H S Shin; B Oliveira
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

3.  The biologic activities of guinea pig antibodies. I. Separation of gamma1 and gamma2 immunoglobulins and their participation in allergic reactions of the immediate type.

Authors:  B Oliveira; A G Osler; R P Siraganian; A L Sandberg
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

4.  Serum C'3 lytic system in patients with glomerulonephritis.

Authors:  R E Spitzer; E H Vallota; J Forristal; E Sudora; A Stitzel; N C Davis; C D West
Journal:  Science       Date:  1969-04-25       Impact factor: 47.728

5.  Chronic glomerulonephritis associated with low serum complement activity (chronic hypocomplementemic glomerulonephritis).

Authors:  R J Pickering; R C Herdman; A F Michael; R L Vernier; H Gewurz; A J Fish; R A Good
Journal:  Medicine (Baltimore)       Date:  1970-05       Impact factor: 1.889

6.  Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement.

Authors:  R J Pickering; M R Wolfson; R A Good; H Gewurz
Journal:  Proc Natl Acad Sci U S A       Date:  1969-02       Impact factor: 11.205

7.  Decreased properdin activity in acute glomerulonephritis.

Authors:  H Gewurz; R J Pickering; G Naff; R Snyderman; S E Mergenhagen; R A Good
Journal:  Int Arch Allergy Appl Immunol       Date:  1969

8.  [Isolation and properties of a beta-glycoprotein from human serum].

Authors:  H Haupt; K Heide
Journal:  Clin Chim Acta       Date:  1965-10       Impact factor: 3.786

9.  Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.

Authors:  C A Alper; F S Rosen
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

10.  Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.

Authors:  V A Bokisch; H J Müller-Eberhard; C G Cochrane
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307
View more
  35 in total

1.  Identification of nephritic factor as an immunoglobulin.

Authors:  D G Williams; A Bartlett; P Duffus
Journal:  Clin Exp Immunol       Date:  1978-09       Impact factor: 4.330

2.  C3 deposition in renal arterioles in the loin pain and haematuria syndrome.

Authors:  P F Naish; G M Aber; W N Boyd
Journal:  Br Med J       Date:  1975-09-27

3.  C3 activator and hypocomplementaemia in a "healthy" woman.

Authors:  A Karstorp
Journal:  Br Med J       Date:  1976-02-28

4.  Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia.

Authors:  J A Charlesworth; D G Williams; E Sherington; P J Lachmann; D K Peters
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

5.  Cellular specificity of murine renal C3 expression in two models of inflammation.

Authors:  B H Ault; H R Colten
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

6.  Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.

Authors:  D Adu; D G Williams
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

7.  Occurrence of C3 nephritic factor and C4 nephritic factor in membranoproliferative glomerulonephritis (MPGN).

Authors:  H Ohi; T Yasugi
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

8.  Mechanisms of activation of the properdin system. Studies on properdin electrophoretic mobility in agarose activation of the alternative pathway.

Authors:  C Adam; D G Williams; D K Peters
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

9.  Studies in vivo of cobra factor and murine C3.

Authors:  M B Pepys
Journal:  Immunology       Date:  1975-02       Impact factor: 7.397

10.  Metabolism of human beta 1H: studies in man and experimental animals.

Authors:  J A Charlesworth; D M Scott; B A Pussell; D K Peters
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.